These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8750405)

  • 1. Effects of lisinopril and bisoprolol on lipoprotein metabolism in patients with mild-to-moderate essential hypertension.
    Saku K; Liu K; Takeda Y; Jimi S; Arakawa K
    Clin Ther; 1995; 17(6):1136-46. PubMed ID: 8750405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four week administration of an ACE inhibitor and a cardioselective beta-blocker in healthy volunteers: no influence on insulin sensitivity.
    Heinemann L; Heise T; Ampudia J; Sawicki P; Sindelka G; Brunner G; Starke AA
    Eur J Clin Invest; 1995 Aug; 25(8):595-600. PubMed ID: 7589016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
    Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
    J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of bisoprolol, a beta 1-selective beta-blocker, on lipid and glucose metabolism and quality of life in elderly patients with essential hypertension].
    Haneda T; Ido A; Fujikane T; Tanaka H; Tanazawa S; Morimoto H; Kato J; Kanaya K; Honda H; Sakai H; Akita N; Hirayama T; Onodera S; Kikuchi K
    Nihon Ronen Igakkai Zasshi; 1998 Jan; 35(1):33-8. PubMed ID: 9564739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lisinopril and low-dose trichlormethiazide on lipoprotein metabolism in patients with mild to moderate hypertension.
    Sasaki J; Tominaga K; Saeki Y; Kawasaki K; Sumida I; Ikeda K; Kato Y; Doi Y; Gondo K; Saku K
    J Hum Hypertens; 1992 Jun; 6(3):233-7. PubMed ID: 1321248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension.
    Dominguez LJ; Barbagallo M; Jacober SJ; Jacobs DB; Sowers JR
    Am J Hypertens; 1997 Dec; 10(12 Pt 1):1349-55. PubMed ID: 9443770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
    Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P
    Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of bisoprolol, a selective beta1-blocker, on glucose metabolism by long-term administration in essential hypertension.
    Owada A; Suda S; Hata T; Miyake S
    Clin Exp Hypertens; 2001 May; 23(4):305-16. PubMed ID: 11349822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system is involved in the mechanism of increased serum asymmetric dimethylarginine in essential hypertension.
    Ito A; Egashira K; Narishige T; Muramatsu K; Takeshita A
    Jpn Circ J; 2001 Sep; 65(9):775-8. PubMed ID: 11548874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS).
    Czuriga I; Riecansky I; Bodnar J; Fulop T; Kruzsicz V; Kristof E; Edes I; ;
    Cardiovasc Drugs Ther; 2003 May; 17(3):257-63. PubMed ID: 14574084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
    Widecka K; Celibała R; Czekalski S
    Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up.
    Saku K; Zhang B; Hirata K; Liu R; Sasaki N; Sakai T; Ying H; Arakawa K
    Clin Ther; 1992; 14(6):813-20. PubMed ID: 1286488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.
    Grassi G; Turri C; Dell'Oro R; Stella ML; Bolla GB; Mancia G
    J Hypertens; 1998 Dec; 16(12 Pt 1):1789-96. PubMed ID: 9869013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisinopril versus atenolol: decrease in systolic versus diastolic blood pressure with converting enzyme inhibition.
    Pannier BE; Garabedian VG; Madonna O; Fouchard M; Darne B; Safar ME
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):775-81. PubMed ID: 1653594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.